@ChinaBio Profile picture

ChinaBio® Group

@ChinaBio

Helping western life science companies achieve success in China.

Similar User
BioCentury photo

@BioCentury

EBD Group photo

@EBDgroup

Graham Combe photo

@CombeGraham

Ying Huang photo

@YingHuang_

流放之忆 photo

@cuiguojie

Week In Review: Tianjin CanSino Staging $160.5 Million Hong Kong IPO $MRK talkmarkets.com/content/stocks…


Week In Review: Grifols Pays $1.9 Billion For 26% Stake In Shanghai RAAS $CASI $BGNE $GRFS $NVO goo.gl/k8XxSX


Week In Review: Nanjing's NJCTTQ Agrees To $4 Billion Package For Abpro Bi-Specific Immunotherapies $ASLN $BCAC goo.gl/VzpxLD


Week In Review: Sciwind, A Hangzhou Biopharma, Raises $29.5 Million For NASH Treatments goo.gl/N17Rr1


Week In Review: New Shanghai Hi-Tech Exchange To IPO Pre-Revenue Companies goo.gl/TjnaHw


Week In Review: China Green Lights Nasdaq-Style Exchange For Young Companies $CIR $BABA $KANG $TCON goo.gl/1mgRbe


Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services $AZN $IRWD $CBMG $BGNE goo.gl/bJytdy


Week In Review: China Life Science Starts Off 2019 With $425 Million In Deals $NVS $SPRO $CBMG $BHVN $ASLN goo.gl/JgmFsj


Week In Review: 2018 Results: China Life Science Investment Hits Record Levels $NVCR $ATNX $ZLAB goo.gl/8gxvpZ


Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019 $AZN $LLY $FGEN goo.gl/sRinBT


Week In Review: Two China Biopharmas Raise $1.4 Billion In Hong Kong IPOs $ZLAB goo.gl/kg6EWZ


Week In Review: China Pharmas Announce Deals Worth $1.5 Billion $RVNC $VBIV $CASI $SPPI goo.gl/nudVRE


Week In Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal With Zymeworks $LLY $HCM $BGNE $MGNX $ZLAB goo.gl/9nSQHX


Week In Review: Alphamab Closes $100 Million Series A For Oncology Candidates $LLY $CASI $BIIB $GILD goo.gl/ct1HyD


Week In Review: CStone Pharma, A Suzhou Oncology Company, Files For Hong Kong IPO $A $CUE goo.gl/nWzYcE


Week In Review: Innovent Completes $421 Million Hong Kong IPO; Will Start Trading Next Week $CASI $ZLAB goo.gl/JxMr5y


Week In Review: Innovent's Hong Kong IPO: Raising $422 Million At $2 Billion Valuation $LLY $APDN $CGIX $HCM goo.gl/zYhgU9


Week In Review: Biosense Exercises $75 Million Option For China Rights To Neovacs' Lupus Immunotherapy $MEIP $BGNE goo.gl/61SBmT


Week In Review: Shanghai Henlius To File For Hong Kong IPO At Valuation Of Over $1 Billion $GILD $CBMG goo.gl/DoiVo6


United States Trends
Loading...

Something went wrong.


Something went wrong.